May 8, 2014 4:01 PM

Pozen cutting jobs as it seeks to reduce expenses

Pozen reported a sharp increase in royalty revenue in the first quarter and said it expects to be profitable for the year. But the Chapel Hill drugmaker also said it has reduced its research and development staff as it seeks to control expenses.

Related content